Skin Microbiome Shifts Detected in Immunotherapy Rash Patients
A City of Hope study explores whether skin bacteria differ between rash-affected and healthy skin in cancer immunotherapy patients.
609 articles
A City of Hope study explores whether skin bacteria differ between rash-affected and healthy skin in cancer immunotherapy patients.
A Phase II trial tests whether blocking herpes virus activity can protect against Alzheimer's disease in early cognitive decline.
A completed Phase 1 trial compared the abuse liability of rapastinel versus ketamine in recreational polydrug users, with implications for safer depression treatment.
MD Anderson researchers evaluated vemurafenib, cetuximab, and irinotecan together to find the optimal dose and safety profile for advanced solid tumors.
A Phase 2 trial testing maraviroc and favipiravir for severe COVID-19 was terminated before completion, leaving efficacy data incomplete.
Swiss researchers completed a 74-patient phase 2 trial exploring optimal dosing schedules for dual checkpoint blockade in metastatic renal cell carcinoma.
A structured neuroplasticity-based program improved functional performance and emotional well-being in community-dwelling older adults with dementia.
VascuFit tests whether periodized high-intensity training can reverse vascular aging in sedentary adults with cardiovascular risk factors.
A German proof-of-concept trial tests whether a maximal five-class antiretroviral regimen can deplete latent HIV reservoirs.
A completed French trial explores how gut and airway microbiota, blood, and sputum biomarkers relate to immunotherapy outcomes in metastatic NSCLC.
A phase 2 trial tests obinutuzumab, ibrutinib, and venetoclax in Richter's syndrome, a deadly CLL transformation with few treatment options.
A feasibility trial combines strength training, balance work, and protein education to help frail older adults with chronic disease stay functional.